Buy CymaBay Therapeutics Stock | CBAY Stock Price & Latest News | Public.com
CBAY

CymaBay Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View CymaBay Therapeutics (CBAY) stock trends here

    About CBAY

    CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 ai...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.16
    -0.24
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.24

    Actual EPS
    Q1 2021

    Stats

    Market Cap$315,5M
    Volume932,02k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.06
    1 Year Low$1.21
    Open$4.64
    High$4.70
    Low$4.25

    Buy any stock with any amount of money.

    Download the App
    Download the app